Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global mannitol market attained a value of USD 479.29 Million in 2025 and is projected to expand at a CAGR of 4.50% through 2035. The market is further expected to achieve USD 744.32 Million by 2035. The trend toward the increased use of biologics, lyophilized formulations, and advanced drug delivery technologies is resulting in greater demand for pharmaceutical grade mannitol, driving the need for capacity expansions by manufacturers and long-term procurement arrangements around the world.
There are two key factors driving the mannitol market growth. On one hand, the growing emphasis by pharmaceutical companies on the development of orally disintegrating tablets is contributing to increased consumption, driven by the pleasant taste, fast dissolvability, and good formability associated with this excipient. Additionally, the growth of the nutraceutical industry is generating new applications for mannitol as an ingredient that helps reduce the presence of sugar in functional food products.
Strategic shifts are being expected within the mannitol market as major players introduce modern manufacturing techniques and produce premium quality compounds. It is important to highlight that in April 2026, Roquette extended its range of pharmaceutical excipients and increased its focus on manufacturing high-purity levels of injectable polyols in order to meet the needs of biopharmaceutical manufacturers. Such a strategy reflects the increased role of mannitol in freeze-dried products, including lyophilized drugs where it acts as a vital bulking and stabilizing agent. According to market research, an increasing number of injectable drugs developed through lyophilization techniques are approved every year which contributes to constant demand for high-quality grades of mannitol.
Pharmaceutical and specialty industries continue evolving and incorporating new types of drugs which positively impact the growth of the global mannitol market. The ingredient becomes widely utilized across solid dosage forms, injectable medications, and therapeutic diets as it provides benefits such as stability and low hygroscopicity and is compatible with most API. Modern particle engineering techniques help manufacturers increase tablet compressibility, which contributes to better performance. Producers are also paying more attention to expanding their regional production capacities to decrease the purchasing risks of pharmaceutical companies. For example, in October 2023, Arna Pharma acquired Pharmaxis’ mannitol respiratory business, strengthening manufacturing capabilities and product commercialization.
Compound Annual Growth Rate
4.5%
Value in USD Million
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Liquid I.V. introduced sugar-free hydration products in India, catering to wellness trends, calorie-aware consumers, and the rising demand for functional beverages. Manufacturers in the mannitol market can hence provide low-calorie sweetening options for hydration products aimed at health-conscious consumer demographics.
AMASS rolled out a range of zero-sugar beverages, using clean-label ingredients and wellness-oriented formulations to appeal to health-focused consumers. Companies can create pharmaceutical and food-grade mannitol components that support innovation in sugar-free and reduced-calorie products.
Coca-Cola expanded its portfolio with Fresca Hard Zero Sugar, responding to growing demand for low-calorie alcoholic beverages. Leveraging such trends, suppliers can collaborate with beverage manufacturers developing sugar-free alcoholic and functional drink formulations, thereby propelling the mannitol market development.
NutraEx launched BI-Sugar, an ingredient designed to reduce sugar absorption, supporting metabolic health and wellness-focused nutrition products. Other companies can also integrate mannitol into functional nutrition products addressing sugar reduction, weight management, and healthier consumption trends.
The rise in biologics and injectable products is leading to an increased requirement for mannitol in pharmaceutical products. Mannitol acts as a bulking and stabilizing excipient for freeze-drying products to help preserve drug stability. Investment by pharmaceutical manufacturers in facilities involved in biologics production is also leading to an increase in the usage of excipients. For example, the FDA continues to approve an increasing number of biologic drugs each year, prompting excipient providers to increase their high purity excipient range, accelerating demand in the mannitol market. Excipient providers, like Roquette and Merck, are concentrating on mannitol grades that can be used in injectable formulations. On the other hand, in November 2025, scientists developed biotechnology-based xylitol production methods utilizing agricultural waste, improving sustainability, cost efficiency, and resource valorization.
There is an increasing use of mannitol in the development of orally disintegrating tablets due to its good taste and cooling effect, apart from compressibility properties. Pharmaceutical firms are increasingly targeting patient-friendly dosage forms, especially for children and elderly patients suffering from swallowing issues. Regulatory authorities in Europe, North America, and Asia continue to provide incentives to promote patient-centered drug development. Companies such as SPI Pharma and Roquette, are offering several grades suitable for direct compression, broadening the mannitol market scope. In January 2026, Huons introduced Mannitol Injection 15% and 20% formulations, expanding osmotic therapy options, and strengthening critical-care pharmaceutical offerings.
The usage of mannitol as a sugar alternative to offer a better taste in sugar-free confectionery, chewing gums, and other functional foods is becoming widespread within the food industry owing to the increasing health issues such as obesity and diabetes resulting from the high consumption of sugar. The governments' health organizations, including WHO, advocate reducing sugar intake among people by providing guidelines in dietary choices, further reshaping the mannitol market dynamics. As a result, major food companies are shifting their attention towards healthier alternatives like mannitol, which not only provides sweetness but can also serve as a bulk ingredient. In June 2026, Tate & Lyle broadened its BioHarvest collaboration, advancing plant-based sweetener molecules supporting sugar reduction, taste optimization, and formulation flexibility.
Major manufacturers of pharmaceutical ingredients are ramping up production facilities in order to ensure high purity levels in line with the global pharmaceutical industry standards. The mannitol market observes a demand for high-grade mannitol, which is used for manufacturing advanced pharmaceutical ingredients, leading companies to upgrade their manufacturing processes and invest in new quality control measures. Some companies in the global market are even enhancing their manufacturing facilities in compliance with GMP and various pharmacopeias. In October 2025, Ashland introduced high-purity sucrose excipients and expanded injectable formulation solutions, enhancing biologic stability, protein protection, and pharmaceutical manufacturing quality.
Manufacturers are increasingly investing in efficient production processes in order to reduce wastage, conserve energy, and improve the use of resources. Policies geared towards creating industries that are environmentally friendly through low emissions are also pushing mannitol market players into developing better production methods. The EU’s sustainable model and the different programs for industrial decarbonization that nations undertake, are driving chemical and ingredients firms to revamp their production infrastructure. In March 2026, Cosmo Energy partnered with Nihon University to develop sugar-derived bio-isobutanol using non-edible biomass feedstocks and sustainable production technologies.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR’s report titled “Mannitol Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Form
Key Insight: As per the mannitol market report, segmentation in terms of form arises due to the differences in operational demands from industry end-users. The powder segment continues to hold dominance owing to its greater flexibility in formulations, good compatibility with pharmaceutical components, and effective usage in tablets and injectables. Growing preference for powder among excipients manufacturers is also a key driving factor. On the other hand, the granular mannitol segment is witnessing increasing demand from producers on account of rising emphasis on process efficiency, better handling, and simpler processing procedures. Increasing preference for automation is helping in adopting granular versions. For example, in May 2024, SweetLeaf introduced a single-ingredient xylitol sweetener with 10 calories per serving, supporting sugar reduction, clean-label formulations, and healthier baking applications.
Market Breakup by Application
Key Insight: The pharmaceutical sector leads the application category owing to the large-scale application in medicine formulation systems, in excipients, and stabilization of biological products. The food industry gains momentum on account of the increasing demand for calorie-free and sugar-free products, accelerating the mannitol market expansion. The surfactant industry uses mannitol in the manufacture of specialty surfactants owing to their reliable performance levels. Personal care products show great growth potential because of unique product innovations and differentiation strategies.
Market Breakup by Region
Key Insight: Demand trends in the mannitol market are closely linked to the strength of pharmaceutical manufacturing activities and the level of industrial development across regions. North America continues to dominate owing to its advanced healthcare industry and value-based pharmaceutical production along with a growing demand for pharmaceutical excipients. Europe continues to remain a key player owing to its quality specifications and pharmaceutical industry activities. Asia Pacific is witnessing the fastest growth in terms of increased investments in the healthcare sector, increased pharmaceutical production, and expanded nutraceutical production. Latin America is benefiting from improving health care accessibility and industrial development initiatives.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By form, the powder category registers the largest share of the market due to pharmaceutical formulation compatibility
The powder form dominates the mannitol market owing to its widespread use in pharmaceutical formulations like tablets, capsules, and lyophilized injection. Pharmaceutical companies are favoring powder mannitol as it possesses excellent flow properties, is non-hygroscopic, and well tolerated by active pharmaceutical ingredients. Increasing usage of orally disintegrating tablet technology and direct compression methods are driving the growth of this type of product. Manufacturers are also introducing special types of powdered grades which enhance compressibility and solubility, and these hence gain preference as a pharmaceutical excipient. In March 2026, MannKind secured FDA approval for Afrezza inhaled insulin in children, expanding needle-free diabetes treatment accessibility and patient convenience.
The fastest growing segment is represented by granulated mannitol as manufacturers look forward to using materials that are easy to handle and produce minimal dust during processing. Granulated mannitol offers superior flow and mixing properties, hence they are suitable for large-scale processing of pharmaceuticals and nutraceuticals. Manufacturers are increasingly opting for granulated mannitol due to its suitability in direct compression technology where ease of handling and increased productivity are necessary. Manufacturers are continuously introducing innovative granulation techniques to introduce premium quality granulated forms of mannitol.
Pharmaceutical applications record notable growth in the market due to expanding drug formulation demand
Pharmaceutical applications are considered to be the largest segment for mannitol due to its use as an excipient, bulking agent, and stabilizer. The compound has vital applications in tablets, capsules, injectables, and lyophilization of biologic drugs where stability of the formulation is important. The growth in development of more user-friendly dosages forms such as orally dissolving tablets is expected to lead to an increase in market growth. Moreover, drug makers prefer the use of mannitol for its chemical inertness and low moisture affinity properties. Innovation in the biologics and specialty drug market is expected to drive the long-term growth of the mannitol market. In November 2023, NiedlFree Technologies developed Ozulin, a needle-free oral insulin spray offering painless diabetes management through advanced nanoparticle-based delivery technology.
The fastest growing application segment for mannitol is the personal care market because of the increased usage of multipurpose compounds for use in oral care, skin care, and cosmetics. Its use in cosmetics is being driven by its moisturizing property, texturizing ability, and ability to enhance the stability of the product. Companies are also manufacturing high-end personal care products which place emphasis on quality and user experience, thus driving demand for specialized polyols in the market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America clocks in the leading market position due to advanced pharmaceutical manufacturing
North America records dominance in the global mannitol market owing to the highly developed pharmaceutical industry in the region, the presence of a developed drug development environment, and strict quality requirements regarding excipients. Many pharmaceutical companies, contract development providers, and biotech organizations are present in the region, and they need high-quality mannitol to create complicated formulations. The demand for such products is further fueled by the development of the region in terms of biologics manufacturing and specialized pharmaceuticals. Manufacturers in North America tend to pay close attention to regulatory compliance, reliable logistics, and high-quality excipients. Chiesi offers commercialized Bronchitol inhalation powder in the United States, expanding mannitol-based respiratory therapies for adult cystic fibrosis patients, since March 2021.
The highest rates of growth can be observed in the Asia Pacific mannitol market because of the rapid development of the pharmaceutical industry and an increase in production capacity for pharmaceutical products in China, India, South Korea, and countries in Southeast Asia. Growing healthcare investments, higher domestic pharmaceutical production, and developing nutraceutical industries are becoming important drivers of mannitol consumption in the region. Moreover, governments are trying to ensure pharmaceutical self-reliance in countries and improve their production capabilities.
The industry is witnessing heightened levels of competitiveness among mannitol companies, who are increasingly concentrating on pharmaceutical grade quality, improved particle engineering, and development of application-specific products. Some of the major players are working toward developing special grades of mannitol for use in biologics, orally disintegrating tablets, and lyophilization applications that demand consistent performance.
In addition, several mannitol market players are emphasizing building robust regional manufacturing facilities in order to ensure safety from logistical problems and increased responsiveness to their customers in the pharmaceutical segment. Yet another significant area of attention among manufacturers is environmentally sustainable production. Industry opportunities lie within the fast-expanding market for biologics, nutraceuticals, and premium personal care products, which are highly reliant on functional ingredients. Companies are taking a strategic stance in partnerships with formulators in the pharmaceuticals industry and are developing excipient-based solutions for differentiation purposes.
Founded in 1865, with headquarters located in Minnesota, United States, Cargill operates as a major international provider of food components and farming-related services. As it offers numerous starch-based compounds, alternative sugars, and niche nutritional substances, demand within food, drink, and medicine sectors remains steady. Despite challenges in sourcing, its global logistics network ensures consistent delivery.
Founded in 1919, Pfanstiehl operates from its base in Illinois, United States, focusing on highly refined pharmaceutical excipients and components for biopharmaceuticals. With a central role in expanding the mannitol sector, it provides mannitol grades suitable for injections, biological drugs, vaccines, and methods of delivering medication. Although less visible than active compounds, its contribution lies in producing exceptionally pure substances needed for modern medicine development.
Established in 2000, with central operations based in Delaware, United States, SPI Pharma delivers essential materials used in medicine production. Its portfolio includes specialized forms of mannitol suitable for tablet compression without prior processing. These ingredients support fast-dissolving oral products along with uniquely shaped dosages. With attention directed toward smooth manufacturing processes, methods that favor ease of intake, and newly developed supportive compounds, the organization enables medicinal developers to refine how their treatments work while reducing time-to-market delays.
Established in 2007, with main offices in Houston, Texas, United States, LyondellBasell Industries N.V. focuses on advanced methods in transforming raw inputs, streamlining supply elements, because of large-volume output capabilities. Companies are adopting greener production processes and advancing molecular innovations, leading to improved ingredient effectiveness across various medical applications. Such efforts influence how substances are developed at scale under evolving environmental standards.
Other key players in the market include Roquette Frères, among others.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Unlock the latest insights with our mannitol market trends 2026 report. Discover regional growth patterns, consumer preferences, and key industry players. Stay ahead of competition with trusted data and expert analysis. Download your free sample report today and drive informed decisions in the market.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
In 2025, the mannitol market reached an approximate value of USD 479.29 Million.
The market is assessed to grow at a CAGR of 4.50% between 2026 and 2035.
The market is estimated to witness healthy growth in the forecast period of 2026-2035 to reach a value of around USD 744.32 Million by 2035.
The major drivers of the market include rising disposable incomes, increasing population, rising demand for mannitol as a food additive, rapid urbanisation, rising cases of diabetes, and growing health consciousness.
Technological advancements, surging innovations, and the increasing end uses of mannitol are expected to be key trends guiding the market.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market.
The different forms of mannitol are powder and granular.
The major applications of mannitol are food industry, industrial, surfactants, pharmaceuticals, and personal care, among others.
The leading players in the global mannitol market are Cargill, Incorporated, Pfanstiehl, Inc., SPI Pharma, Lyondellbasell Industries N.V., Roquette Frères, Others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Form |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 2,499
USD 2,249
tax inclusive*
Single User License
One User
USD 3,999
USD 3,599
tax inclusive*
Five User License
Five User
USD 4,999
USD 4,249
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.